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A B S T R A C T
The apolipoprotein E gene (APOE) ε4 allele has a strong and manifold impact on cognition and neuroimaging
phenotypes in cognitively normal subjects, including alterations in the white matter (WM) microstructure. Such
alterations have often been regarded as a reflection of potential thinning of the myelin sheath along axons, rather
than pure axonal degeneration. Considering the main role of APOE in brain lipid transport, characterizing the
impact of APOE on the myelin coating is therefore of crucial interest, especially in healthy APOE-ε4 homozygous
individuals, who are exposed to a twelve-fold higher risk of developing Alzheimer's disease (AD), compared to
the rest of the population.
We examined T1w/T2w ratio maps in 515 cognitively healthy middle-aged participants from the ALFA study
(ALzheimer and FAmilies) cohort, a single-site population-based study enriched for AD risk (68 APOE-ε4
homozygotes, 197 heterozygotes, and 250 non-carriers). Using tract-based spatial statistics, we assessed the
impact of age and APOE genotype on this ratio taken as an indirect descriptor of myelin content.
Healthy APOE-ε4 carriers display decreased T1w/T2w ratios in extensive regions in a dose-dependent
manner. These differences were found to interact with age, suggesting faster changes in individuals with more ε4
alleles.
These results obtained with T1w/T2w ratios, confirm the increased vulnerability of WM tracts in APOE-ε4
healthy carriers. Early alterations of myelin content could be the result of the impaired function of the ε4 isoform
of the APOE protein in cholesterol transport. These findings help to clarify the possible interactions between the
APOE-dependent non-pathological burden and age-related changes potentially at the source of the AD patho-
logical cascade.
1. Introduction
The ε4 allele of the apolipoprotein E gene (APOE), which is the main
genetic risk factor for late-onset Alzheimer's disease (AD), has also a
strong and manifold impact neuroimaging phenotypes (Reinvang et al.,
2013; Fouquet et al., 2014) in cognitively normal subjects. In
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cognitively intact individuals, carrying the ε4 allele has been shown to
exert a dose-dependent influence on amyloid accumulation (Reiman
et al., 2009), glucose metabolism (Reiman et al., 2001) and the brain
structure at macro- and microscopic levels (Fouquet et al., 2014). Ef-
fects of APOE-ε4 on gray matter have been assessed by many studies
(Cacciaglia et al., 2018; Protas et al., 2013; Lemaitre et al., 2005; Chen
et al., 2007). A growing body of evidence has also been supporting an
association between the APOE-ε4 status and white matter (WM) in-
tegrity. A review of existing results was included in Operto et al., 2018.
In this recent study, microstructural alterations in WM integrity have
been reported in cognitively normal carriers of the ε4 allele using dif-
fusion-weighted imaging (DWI), with the largest differences involving
higher mean (MD) and radial (RD) rather than changes in axial diffu-
sivity (AxD), in extended regions including bilateral main associative
tracts. Such directional pattern in diffusion metrics has often been re-
garded as a reflection of potential thinning of the myelin sheath, rather
than Wallerian degeneration (Wang et al., 2015; Zhang et al., 2012;
Song et al., 2002). Myelin quantification requires the implementation of
specific imaging protocols (see Heath et al. (2018) for a recent review).
Otherwise, myelination cannot be strictly measured using standard
single-shell DWI techniques and can only be speculated through the
appreciation of combined diffusivity metrics.
Myelin is produced by oligodendrocytes in the central nervous
system and forms an insulating layer around axons, which provides key
core functions related to signal transmission. Given the main role of
APOE in the transport of cholesterol which is a major component of
myelin, the observed lower functionality of the ε4 isoform is suspected
to contribute to the increased risk to AD observed in ε4-carriers (Liu
et al., 2013a).
Impacts of common risk factors on demyelination and its con-
tribution to cognitive decline are suspected but have been poorly in-
vestigated in human populations (Dean et al., 2015; Peters, 2002).
Bartzokis and colleagues have introduced a model describing the course
of myelin integrity across lifespan, following an inverted U-shape
(Bartzokis, 2011), its association with cognitive efficiency metrics (Lu
et al., 2013) and how its breakdown may relate to neuropathological
processes such as incipient AD (Bartzokis, 2004; Bartzokis et al., 2007).
Some results have also supported the proposed concept of retrogenesis,
suggesting that the latest tracts to myelinate would be the most vul-
nerable to age and pathologies, and therefore the first to disrupt
(Benitez et al., 2014; Gao et al., 2011; Stricker et al., 2009; Brickman
et al., 2012; Reisberg et al., 2002). AD-related myelin changes have
long been considered as secondary aging effects and hence literature on
the subject is still lacking. Dean et al. (2017) in a recent study report
widespread age-related changes especially in late-myelinating brain
regions and negative associations between relaxometry measures across
WM and levels of CSF biomarkers in cognitively asymptomatic parti-
cipants. Bouhrara et al. (2018) showed decreased myelin water fraction
in subjects suffering mild cognitive impairment, vascular dementia or
AD, compared with old controls. Altogether these results shed light on
the role myelin and oligodendrocytes may play in the AD continuum
and support a potentially emerging value of myelination as biomarker,
in line with the recent attention given to micro- and macrostructural
changes in WM in the risk and progression of AD (Nasrabady et al.,
2018).
It has been proposed that the ratio of T1-weighted (T1w) over T2-
weighted (T2w) Magnetic Resonance Imaging (MRI) intensities could
render myelin-enhanced contrast images (Glasser et al., 2014), which
may be well-suited in contexts where specific multi-compartment ac-
quisitions are not available or feasible. The method is based on the
assumption that histological measures of myelin content covary with
both T1w and T2w intensity, but in opposite directions (Glasser and
Van Essen, 2011). It was initially proposed for cortical mapping of
myelin, then was extended to the whole brain (Ganzetti et al., 2014)
and met a variety of applications with special emphasis in develop-
mental studies (Lee et al., 2015; Soun et al., 2017; Lebel and Deoni,
2018), neurodegenerative diseases e.g. MS (Righart et al., 2017),
schizophrenia (Iwatani et al., 2015), Alzheimer's disease (Yasuno et al.,
2017; Pelkmans et al., 2019) and the healthy brain (Shafee et al., 2015).
The present study aims at studying the impact of APOE-ε4 allele
load on white matter myelin, using T1w/T2w maps as a proxy for
myelin content, and its interaction with age. To this end, we generated
T1w/T2w ratio maps following the approach introduced by Glasser and
Van Essen (2011) and performed group analysis using non-parametric
skeleton-based statistics focused on WM tracts (Smith et al., 2006).
Such method has been extensively used to explore microstructural
changes using diffusion metrics and still to our knowledge has never
been employed before for this type of data.
Our initial hypothesis was based on that if previous differences
observed with DWI were due to changes in white matter myelination,
then those changes would potentially be captured by T1w/T2w maps.
We hence hypothesized that subjects at risk of developing AD would
show negatively affected ratio values in regions matching the differ-
ences observed in diffusion imaging (long associative tracts) (Operto
et al., 2018). The high number of APOE-ε4 homozygotes allowed us to
better understand the impact of this allele according to the number of
carried copies on the microstructural properties of the brain. We as-
sessed the effects of APOE-ε4 load, status, age, and sex. We hypothe-
sized that T1w/T2w ratio values would decline with age, as expected
with the course of myelination at this age range. Effect of sex was re-
ported for exploratory purposes. Age by genotype interaction was also
tested.
2. Methods and materials
2.1. Study participants
The participants of this study were recruited in two steps. In a first
phase, 2743 cognitively healthy volunteers aged between 45 and
74 years were registered in the ALFA study (ALzheimer and FAmilies), a
large cohort program aimed at identifying neuroimaging biomarkers of
preclinical AD in the general population (Molinuevo et al., 2016). Ex-
clusion criteria included performance below established cutoffs for a
number of cognitive tests as well as the presence of any psychiatric or
any other clinically significant condition (Molinuevo et al., 2016). In a
second phase, after APOE genotyping, cerebral MRI examination was
proposed to all participants homozygous (HO) for the ε4 allele and all
carriers of the ε2 allele, along with ε4-heterozygous (HT) and non-
carriers (NC) matched for age and sex. This strategy resulted in the
selection of 576 study participants, 61 of whom had to be excluded
because of either MRI incidental findings (32), poor image quality (12)
or processing issue (17), resulting in a final sample size of 515. De-
mographic characteristics of the participants are summarized in
Table 1.
For the statistical analyses, participants were pooled according to
the cumulative number of ε4 alleles, that is, noncarriers as well as ε4-
heterozygous and ε4-homozygous individuals. Since homozygous sub-
jects were significantly younger than noncarriers and heterozygotes
(Table 1), age was included as a covariate in all subsequent analyses.
2.2. APOE genotyping
Total DNA was obtained from the blood cellular fraction by pro-
teinase K digestion followed by alcohol precipitation. Samples were
genotyped for two single nucleotide polymorphisms (SNPs), rs429358
and rs7412, determining the possible APOE isoforms: ε1, rs429358
(C)+ rs7412 (T); ε2, rs429358 (T)+ rs7412 (T); ε3, rs429358
(T)+ rs7412 (C); and ε4, rs429358 (C)+ rs7412 (C). Of the 515 par-
ticipants, 153 were ε3/ε4 carriers, 146 were homozygous for the ε3
allele, 104 were ε2/ε3 carriers, 68 were homozygous for the ε4 allele
and 44 were ε2/ε4. The allele frequencies were in Hardy-Weinberg
equilibrium.
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2.3. Cognitive measures
The Memory Binding Test (MBT) (Buschke, 2014) was used to
evaluate verbal episodic memory. This test assesses immediate and
delayed retention of verbal information (after a lapse of 25 to 35min)
through a controlled learning process of two lists of 16 words belonging
to 16 different semantic categories presented in the same order. Further
detail on the administration procedure of the MBT and an exhaustive
description of each of the variables can be found in (Gramunt et al.,
2015). MBT yielded seven main outcomes corresponding to two main
areas: learning and immediate recall, and delayed recall. Executive
function was assessed by means of five WAIS-IV subtests: the Digit span
(immediate and working memory): forward, backward and sequencing;
Coding subtest (processing speed and attention); Matrix reasoning and
Visual puzzles (fluid intelligence); and Similarities (abstract verbal
reasoning). We summarized these scores in two Z scores, one for
memory and one for executive functions, by computing arithmetic
means of individual Z scores from the original score values.
2.4. Image data acquisition
All brain MRI data were acquired on a single standard 3 T General
Electric scanner (GE Discovery MR750 W). Structural 3D high-resolu-
tion T1-weighted images were collected in the sagittal plane using a fast
spoiled gradient-echo (FSPGR) sequence implementing the following
parameters: voxel size= 1mm3 isotropic, Repetition Time
[TR]=6.16ms, Echo Time [TE]= 2.33ms, Inversion Time
[TI]= 450ms, matrix size= 256×256×174, flip angle= 12°. T2
and T2*-weighted sequences were acquired in the axial plane with a
voxel size of 1× 1×3mm and the following parameters: fluid at-
tenuation inversion recovery (FLAIR: TR/TE/TI= 11,000/90/2600 ms,
flip angle= 160°), fast spin echo (TR/TE=5000/85ms, flip
angle= 110°), and gradient echo (GRE: TR/TE=1300/23ms, flip
angle= 15°).
The DWI protocol employed a spin-echo echo-planar imaging se-
quence with one T2-weighted baseline (b= 0), 64 b=1000 s·mm−2
diffusion-weighted volumes acquired with 64 distinct diffusion-en-
coding directions. The field of view was 256× 256mm, and the ima-
ging matrix was 128×128 with 56 slices and slice thickness 2mm,
giving 2-mm isotropic voxels.
All scans were visually assessed for quality and incidental findings
by a trained neuroradiologist (Brugulat-Serrat et al., 2017). This re-
sulted in the exclusion of ten participants due to the presence of a
meningioma, and of 37 participants due to susceptibility, motion arti-
facts or segmentation problems, resulting in a total of 515 images ready
for subsequent analyses.
2.5. Image processing
The general workflow included first the generation of individual
T1w/T2w maps, then the group analysis over the main fiber tracts of
WM.
2.5.1. Generation of individual T1w/T2w ratio maps
T1w and T2w images were converted to NIfTI format and analyzed
using a similar method as proposed by Glasser and Van Essen (2011).
Brain mask extraction was performed on raw T1w images using FSL
BET to facilitate subsequent coregistration with T2w images. BET's
parameters were fine-tuned for every subject so as to achieve correct
brain extraction after individual visual inspection. Raw T2w images
were then rigidly coregistered over T1 masked images using the ANTs
toolbox (using mutual information as cost function) (Avants et al.,
2009) and ratio maps were generated dividing T1 by T2 intensities.
Since group analysis is done over a skeletonized version of WM ob-
tained using DWI data, T1w/T2w ratio maps were aligned to DWI b=0
maps using ANTs elastic coregistration.
2.5.2. Creation of the WM skeleton and projection of the data
DWI images were first denoised with the overcomplete local PCA
method by Manjón et al. (2013), then corrected for eddy current dis-
tortions and head motion (using FSL's eddy_correct, default para-
meters). Data analysis was then performed using tools from the FMRIB
Software Library software suite (Jenkinson et al., 2012). Fractional
anisotropy (FA), MD, AxD and RD maps were generated using DTIFit
that fits a diffusion tensor model at each voxel. The FA output images
were used as input for Tract-Based Spatial Statistics (TBSS) (Smith
et al., 2006). TBSS is a pipeline - part of the FSL toolbox - which has
been broadly used in DWI studies, including an image processing and
statistical analysis part, both carried out consecutively. In this pipeline,
intersubject matching is achieved by projecting unsmoothed data on
skeletons representing the center of the WM fiber bundles and sub-
sequent statistical analysis is done on the projected data relying on a
non-parametric permutation-based technique, hence mitigating some
limitations of the standard voxel-based morphometric approach. It
consists of the following steps. All subjects' FA data were coregistered to
the FMRIB58 FA template using FMRIB's Non-linear Image Registration
Tool (FNIRT). The mean FA image was generated and then “thinned”,
by non-maximum-suppression perpendicular to the local tract structure,
to create a mean FA skeleton, which represents the centers of all tracts
common to the group. The mean skeleton was thresholded and binar-
ized at FA > 0.2. T1w/T2w maps were warped to the same inter-
subject reference space using individual transformations obtained from
the coregistration of the FA maps. Each subject's aligned data - in-
cluding FA and T1w/T2w maps - was finally projected onto the mean
Table 1
Sample characteristics.
Total sample (N=515) NC (N=250) HT (N=197) HO (N=68) Inferential statistics
M SD M SD M SD M SD
Agea 58.00 7.41 58.40 7.55 58.57 7.35 54.94 6.18 F= 6.88; p < .01
Educationa 13.64 3.57 13.62 3.61 13.75 3.53 13.38 3.46 F= 0.27; p= .76
MMSEb 29.04 1.08 29.00 1.12 29.02 1.10 29.26 0.77 F= 1.54; p= .22
TFRb 16.47 5.16 16.23 5.15 16.37 5.12 17.73 5.12 F= 2.24; p= .11
TPRb 24.11 4.50 23.72 4.84 24.24 4.23 25.19 3.68 F= 2.84; p= .06
WMHc 3.18 [1.09, 3.65] 3.22 [1.13, 3.41] 3.03 [1.08, 3.70] 3.47 [1.13, 3.82] H=0.60; p= .65
Fazekas scales 0: 247 1: 221 2: 39 3:2 0: 113 1: 115 2: 17 3: 2 0: 101 1: 80 2: 14 0: 33 1: 26 2: 8 χ2= 3.82; p= .43
Male/female 201/314 88/162 88/109 25/43 χ2= 4.32; p= .12
NC=APOE-ε4 Non-carriers; HT=APOE-ε4 Heterozygous; HO=APOE-ε4 Homozygous; MMSE=Mini-Mental State Examination score; TPR=Total Paired Recall;
TFR=Total Free Recall;; WMH=White Matter Hyperintensities; M=mean; SD= standard deviation.
a Indicated in years.
b Cognition data was not available for 15 subjects.
c Indicated in mL. Mean value is presented along with first and third quartiles. Data was not available for 6 subjects.
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FA skeleton and the resulting projected data fed into voxelwise group
analysis.
2.6. Statistical analysis
Group-related differences were assessed using a voxel by voxel
permutation nonparametric test (5000 permutations) with threshold-
free cluster enhancement, as performed by the Randomise tool avail-
able in FSL (Winkler et al., 2014). All results are shown at P < .05
corrected for multiple comparisons across space. Correction for mul-
tiple testing was applied using the default familywise error rate control
with threshold-free cluster enhancement as implemented in Randomise
and as described elsewhere (Winkler et al., 2014; Smith and Nichols,
2009).
We performed voxelwise multiple linear regression analysis using
two main models, the first one to measure the effect of the number of
APOE-ε4 alleles on skeletonized T1w/T2w maps and the second one
which modeled the interaction effect with age on top of the main effect
of APOE genotype. We partitioned genetic variance by including three
dummy regressors coding for the number of ε4 alleles carried. The first
model included age and sex as confounding variables (5 regressors in
total). The second one only included sex, as age by genotype interaction
was the effect of interest. Considering the expected nature of the course
of myelination across time, age was modeled as a quadratic term cen-
tered at age 50, matching with descriptions from lifespan studies
(Sherin and George, 2011; Yeatman et al., 2012; Grydeland et al.,
2018). This second model resulted in a design matrix with 7 regressors,
one for sex as covariate, 3 for the dummy-coded APOE genotypic groups
(NC, HT, HO; main effect) and 3 for the interaction between APOE and
age2 (centered at 50 years).
We compared T1w/T2w ratios to assess the different components of
the effects of APOE genotype among dominance (ε4 carriers versus non-
carriers), recessivity (homozygotes versus others) and additivity (cor-
relation with the number of ε4 alleles carried), in both directions (po-
sitive and negative correlations).
2.7. Supplementary analyses
In order to control for potential biasing effects in our dataset and to
compare results across modalities, we repeated the analysis using the
exact same models/contrasts over parametric maps obtained by DWI on
the same participants. The first model (main effect of APOE) matches
the one used in Operto et al., 2018. The second one (interaction with
age) is the same as the one used with T1w/T2w ratio maps. Results are
presented in Appendix A (Supplementary Data).
A complementary analysis was performed to rule out the potential
Fig. 1. Main effect of age on T1w/T2w ratio. A strong negative association was found between age and T1w/T2w ratio in extensive regions. The WM skeleton is
shown in green. Supra-threshold clusters are presented in colors from dark red to white (1-p > .95, familywise error rate- and threshold-free cluster enhancement-
corrected).
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impact of white matter hyperintensities (WMH), both at global and
voxel-wise levels. To this end, WMH masks were segmented from fluid-
attenuated inversion recovery images of the same individuals using a
method described previously (Sudre et al., 2015; Operto et al., 2018)
and any voxel identified as a lesion in any subject of the studied sample
was removed from the analysis. A threshold of 0.9 was used on the
original probability maps yielded by the segmentation algorithm to
generate binary masks which were fed into TBSS to exclude lesion
voxels from the analysis. Global effects of WMH load were also assessed
by introducing global WMH volumes as confounders in the statistical
models. Independently, potential impact of pathological levels of WMH
was evaluated by using Fazekas scores instead as confounders.
We also looked for potential associations between T1w/T2w ratio
values and cognitive scores assessed by memory and executive tasks.
We used different models for each score among total paired recall
(TPR), total free recall (TFR), coding subtest (processing speed) and the
two Z scores measuring memory and executive functions, respectively,
including - for each of these models - age, sex and APOE genotype as
confounders.
3. Results
3.1. Main effect of age
There was a significant main effect of age on T1w/T2w ratio in the
vast majority of the skeletonized WM (Fig. 1), demonstrating previously
well-documented results regarding age-related changes in myelination
through late-middle age.
3.2. Main effect of APOE genotype
We found significant main effects of APOE-ε4 on the T1w/T2w
maps. Fig. 2 shows the TBSS map for the significant clusters where
APOE-ε4 carriers displayed decreased values compared with non-car-
riers in extended regions of the skeletonized WM. These regions in-
cluded forceps minor, bilateral superior longitudinal fasciculus (SLF),
corpus callosum, corona radiata, inferior fronto-occipital fasciculus
(IFOF), left inferior longitudinal fasciculus (ILF) and left anterior tha-
lamic radiation (ATR) (tracts from the John Hopkins University Atlas
(Wakana et al., 2004)). The observed effects reached statistical sig-
nificance for the dominant and additive models, therefore suggesting
significant differences between non-carriers and carriers and also in a
dose-dependent manner. Significant clusters in the additive contrast
map share a 48% of suprathreshold voxels with the dominant contrast,
Fig. 2. - Effect of the number of APOE-ε4 alleles on T1w/T2w (from top to bottom - dominant and additive components) -.
no recessive component was observed - only contrast maps associated with lower T1w/T2w in ε4 carriers showed significant voxels. The WM skeleton is shown in
green. Supra-threshold clusters are presented in colors from dark red to white (1-p > .95, familywise error rate- and threshold-free cluster enhancement-corrected).
Fig. 3. Main effect of the number of APOE-ε4 alleles on T1w/T2w ratio across fiber tracts. Each bar represents the mean value extracted from the corresponding tract
ROI (from the Johns Hopkins University white matter atlas) along with standard error (confidence interval: 95%). Significant tracts are displayed only (p < .05
familywise error rate corrected). NC=APOE-ε4 Non-carriers; HT=APOE-ε4 Heterozygous; HO=APOE-ε4 Homozygous.
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while the vast majority (> 99%) of voxels from the additive contrast
were also significant in the dominant one. Fig. 3 represents these
changes between APOE groups across fiber tracts.
3.3. Interaction APOE genotype x age
We found a significant negative interaction between the number of
APOE-ε4 alelles and age in extensive bilateral regions of the WM in both
the recessive and the additive contrast (Fig. 4). These regions included,
by decreasing order of spatial extent, forceps minor, bilateral SLF, ATR,
corona radiata, right IFOF and corpus callosum in both contrasts. Sig-
nificant clusters in the additive contrast map share a 93% of supra-
threshold voxels with the recessive contrast. In these areas ε4 carriers
displayed significantly decreased T1w/T2w ratio with respect to non-
carriers. This effect was shown to be dose-dependent with respect to the
number of ε4 alleles and stronger in ε4 homozygotes compared to the
rest of the subjects. Fig. 5 plots values derived from bilateral SLF with
respect to age and genotype group (corrected for sex), hence depicting
how T1w/T2w ratio taken in SLF depart in homozygotes as compared
to other groups.
3.4. Main effect of sex
T1w/T2w ratios were significantly lower in male participants in a
limited set of regions (Fig. 6), mainly in the left hemisphere, including
left SLF, ILF and IFOF and part of the forceps major.
3.5. Association with cognitive performance
We found no significant association between any cognitive score
(among TPR, TFR, coding subtest and Z scores for memory/executive
functions) and T1w/T2w ratios.
3.6. Effect of vascular factors
No voxel demonstrated a significant association between any
parametric map and global volumes of WM lesions or Fazekas scores in
this dataset. Similarly, no global or regional effect of WMH load was
detected in these respective complementary analyses.
4. Discussion
Myelin alterations in subjects at risk of developing AD are still un-
derstudied to date in comparison to existing literature on micro-
structural integrity as measured using DWI. In contrast, changes in
diffusion metrics have regularly been interpreted as potentially in-
dicating a loss in myelin content in subjects at risk of developing the
disease. Still, myelin cannot be measured using standard single-shell
DWI, and can only be speculated through the appreciation of combined
diffusivity metrics. We hypothesized that subjects at risk of developing
AD would show negatively affected ratio values in regions matching the
ones observed in diffusion imaging taking T1w/T2w ratios as indirect
measures of myelin content. T1w/T2w ratio has been extensively used
in previous research as a non-quantitative descriptor of cortical mye-
lination, but rarely in WM studies (Chen et al., 2017). Results from this
present study show significant decreases of this ratio in APOE-ε4 car-
riers in extended regions of the WM in a cognitively normal population.
Across all tested models/contrasts, APOE-ε4 carriers never showed
significant increases of this ratio. The previously described patterns in
DWI (increased RD and MD but not AxD) together with similar results
in healthy infants (Dean et al., 2014), support our previous
interpretation that such changes would reflect developmental altera-
tions related to myelin content in ε4 cognitively carriers. As speculated
in Operto et al. (2018), by lacking functional isoforms of the ApoE
protein, ε4 homozygotes may have thinner myelin sheaths than what
would correspond to their age. Altered myelination would impact ne-
gatively transmission speed and consequently require a higher meta-
bolic consumption to sustain cognitive performance within normality.
As a result, and in combination with other metabolic deficits observed
in cognitively normal ε4 carriers, these changes might contribute to the
increased vulnerability of this group to brain insults associated with
AD.
On the other hand, the interaction between APOE-ε4 and age ob-
served in the present study can be interpreted as a higher vulnerability
of carriers to age-related processes and/or the presence of AD patho-
logical changes. Importantly, differences in T1w/T2w were found sig-
nificant in both dominant and additive contrasts, suggesting a main
effect of the ε4 allele in a dose-dependent manner. Mirroring previous
observations made in DWI studies, the effects of APOE on this ratio are
observed in extensive regions of the white matter. In particular, SLF,
known to be primarily affected in AD (Adluru et al., 2014; Douaud
et al., 2011; Pievani et al., 2010; Stricker et al., 2009) and in mild
cognitive impairment (Liu et al., 2013b; Amlien and Fjell, 2014), was
among the tracts showing the strongest association. Some of the largest
effects are also found in forceps minor and long associative tracts such
as bilateral SLF, ILF, IFOF. Commissural fibers (e.g. corpus callosum
and forceps minor) or limbic system tracts (cingulum) tend to show a
rather dominant effect. In contrast, associative tracts (SLF, ILF, IFOF)
display a more additive one. Associative tracts are also known to be
composed of late-myelinating fibers (Welker and Patton, 2012), hence
potentially more vulnerable (Benitez et al., 2014) according to the
retrogenesis model.
We also replicated previous observations from Operto et al. (2018)
using the same model/contrasts on DWI data, still without finding any
interaction between age and ε4 status in that modality. Several studies
reported different age trajectories of DWI metrics across APOE groups
in cognitively normal participants, in particular in older samples. In this
respect, it might be interpreted that T1w/T2w ratio maps show a higher
sensitivity as compared to diffusion imaging to detect myelin-related
changes. Still, such difference across modalities is open to various
possible interpretations: either the measures provided by the two
modalities may address the same common entity, e.g. myelination,
therefore such difference would indeed reflect a higher sensitivity of
T1w/T2w ratio in detecting the onset of demyelination as compared to
DWI; or these measures could possibly relate to compounds which are
different albeit related, with T1w/T2w consequently capturing the
earlier of two sequential events, while effect on DWI would still be
independent of age at that current stage. Head to head comparison and
the assessment of the longitudinal evolution of these measurements
against more specific measurements of myelin content are required to
explore further these dynamics.
T1w/T2w ratio was initially proposed as an indirect, non-quanti-
tative, measure of myelin content (Glasser et al., 2014) and rapidly met
interest in a substantial amount of studies (Shafee et al., 2015). A
number of considerations have also been raised over the years re-
garding reliability with respect to tailored acquisition protocols (Deoni
et al., 2008; Heath et al., 2018; Hagiwara et al., 2018), or other factors
e.g. tissues or groups with different pathological conditions. Some au-
thors also advocate for bias correction and intensity normalization prior
to T1w/T2w ratio calculation (Ganzetti et al., 2014) in particular to
compensate for interscanner variability in the context of multisite stu-
dies. We believe that having acquired it on a single scanner on
Fig. 4. Interaction between age and APOE-ε4 on T1w/T2w (from top to bottom - recessive and additive components) -.
no dominant component was observed - only contrast maps associated with lower T1w/T2w in ε4 carriers showed significant voxels. The WM skeleton is shown in
green. Supra-threshold clusters are presented in colors from dark red to white (1-p > .95, familywise error rate- and threshold-free cluster enhancement-corrected).
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Fig. 5. Effect of aging and the number of APOE-ε4 alelles on T1w/T2w ratios (unitless) in the SLF area. Each dot represents a subject (red: ε4 homozygotes [HO],
orange: ε4 heterozygotes [HT], blue: non-carriers [NC]). Quadratic regression (by age correcting for sex) is displayed (solid curves) for each APOE group.
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cognitively healthy participants preserves our dataset reasonably from
these variations. We also fairly assume that the use of a permutation-
based technique for group comparisons is particularly suited to the case
of non-quantitative descriptors, which might fail the general statistical
assumptions in standard parametric approaches.
Aside from this, to which particular signal issued from myelin
content T1w/T2w ratios are sensitive is still being debated as well.
Inconsistent correlations with histology, MT ratios (Arshad et al.,
2017), multi-echo T2 (Uddin et al., 2018), or relaxometry (Hagiwara
et al., 2018) suggest that T1w/T2w ratio may also be sensitive to ad-
ditional microstructural properties such as axonal diameter (Arshad
et al., 2017) or be driven by external influences, i.e. iron accumulation,
calcium content, inflammation or atrophy (Uddin et al., 2018;
Hagiwara et al., 2018). Nevertheless, while it is acknowledged that
T1w/T2w ratio is not a specific index of myelin, it may still be re-
cognized as a useful proxy in particular for group comparisons, such as
in recent studies in multiple sclerosis (Nakamura et al., 2017; Righart
et al., 2017). More research is needed both to better characterize the
intimate nature of the T1w/T2w signal and more generally to address
the true impact of demyelination in subjects at risk of developing AD.
In the AD continuum, structural markers are known to depart from
their normal course long before cognitive decline typically begins.
Additional pathological markers, such as cerebrospinal fluid ratios and
brain amyloid burden, are thus required in order to screen preclinical
subjects among cognitively normal individuals. In this regard, this
present study is currently limited by the absence of these markers.
Cognitively healthy APOE-ε4 homozygotes have been reported to show
a significantly higher prevalence of cerebral amyloid pathology. At the
mean age of our homozygote group (55 years), approximately 50% of
these individuals display abnormal levels of amyloid biomarkers, as
compared with only 10% of non-carriers and about 20% of carriers of a
single ε4 allele (Jansen et al., 2015). Besides, T1w/T2w ratio might
show a positive association with Aβ accumulation (Bartzokis et al.,
2007), according to recent results (Yasuno et al., 2017; Pelkmans et al.,
2019). Still, such impact, as it was suggested, would come in a direction
contrary to the one we find for the APOE-ε4 status, therefore pin-
pointing the strength of the effect in our dataset regardless of the
possible underlying amyloid charge. Eventually, access to follow-up
information and complementary examination including positron emis-
sion tomographic imaging and lumbar puncture (Molinuevo et al.,
2016) will allow us to mitigate this risk and to account for the influence
of Aβ pathology and to better stratify our dataset with respect to pre-
clinical AD research criteria.
The major strength of this study lies in having recruited a relatively
young, cognitively healthy sample, with a very large number of APOE-
ε4 homozygotes. This allowed us to study individuals at three levels of
risk, thus building on most published studies that compared carriers vs
non-carriers. In complement to results obtained on DWI data on the
Fig. 6. Main effect of sex (females>males) on T1w/T2w ratios. The WM skeleton is shown in green. Supra-threshold clusters are presented in colors from dark red to
white (1-p > .95, familywise error rate- and threshold-free cluster enhancement-corrected).
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same participants, this present study adds to the emerging evidence that
myelination may represent an important biomarker in the earliest
stages of AD. This confirms the need for further investigation based on
myelin imaging in order to specifically discriminate changes in myeli-
nation against other potential alterations in WM. This could resultantly
pave the way for new promyelinating therapeutic strategies.
5. Conclusions
Our results show significantly decreased T1w/T2w ratio values in
the WM of cognitively healthy carriers of the APOE ε4 allele in a dose-
dependent manner. Such variations in T1w/T2w ratio are consistent
with differential changes previously observed in DWI metrics, giving
further support to the interpretation of an alteration of the myelin
sheath of axons at a stage preceding axonal loss. Further research in-
volving specific myelin mapping sequences is required in order to de-
cipher the observed discrepancies between T1w/T2w and DWI, and to
achieve quantitative comparisons across APOE-ε4 genotypic groups.
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